Skip to content

Drug interactions

Sirolimus + Talquetamab

Severity: Moderate

Sirolimus and Talquetamab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cytokine release syndrome caused by talquetamab temporarily suppresses CYP enzyme activity and may raise sirolimus concentrations. This is most relevant during step-up dosing and for a couple of weeks after the first treatment dose.

What this interaction means in plain words

Sirolimus and Talquetamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Sirolimus belongs to Miscellaneous; Talquetamab belongs to Oncology.

Evidence level: Low

Why it happens

Cytokine-mediated downregulation of CYP3A4 reduces sirolimus clearance.

What to do

Monitor sirolimus trough concentrations and signs of toxicity during step-up dosing and any CRS episode. Adjust the sirolimus dose as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sirolimus and Talquetamab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sirolimus with Talquetamab?

MediHelp rates the interaction as moderate. Sirolimus and Talquetamab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cytokine release syndrome caused by talquetamab temporarily suppresses CYP enzyme activity and may raise sirolimus concentrations. This is most relevant during step-up dosing and for a couple of weeks after the first treatment dose.

How serious is the interaction between Sirolimus and Talquetamab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor sirolimus trough concentrations and signs of toxicity during step-up dosing and any CRS episode. Adjust the sirolimus dose as needed.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in